1王树声.广西90年代初人口死亡原因抽样调查研究[M].第1版.广西:广西民族出版社,1998.51.
2 Yoshida S,Kurokohchi K,Anma K,et al.Clinical significance of lens culinaris agglutinin reactive fraction of serum alpha fetoprotein in patients with hepatocellular carcinoma[J].Int J Oncol,2002,20(2):305-309.
3曾益新.肿瘤学(供研究生用)[M].第2版.北京:人民卫生出版社,2004. (101,269).
4 Hanash S.Disease proteomics[J].Nature,2003,422(6928):226-232.
5 Pandey A,Mann M.Proteomics to study genes and genomea[J].Nature,2000,405 (6788):837-846.
6 Zhang Z,Bast RCJR,Yu YH,et al.Three biomaikers identified from serum proteomic analysis for the detection of early stage ovarian cancer[J].Cancer Res, 2004,64(16):5882-90.
7 Poon TC,Johnson PJ.Proteome analysis and its impact on the discovery of serological tumor markers[J].Clin Chim Acta,2001,313(122):231-239.
8 Steel LF,Shumpert D,Trotter M,et al.A Strategy for the comparative analysis of serum proteomes for the discovery of biomarkers for hepatocellular carcinoma[J]. Proteomics,2003,3(5):601-609.
9 Lee IN,Chen CH,Sheu JC,et al.Identification of complement C3a as a candidate biomarker in human chronic hepatitis C and HCV-related hepatocellular carcinoma using a proteomics approach[J].Proteomics,2006,6(9):2865-2873.
10 ParadisV,Degos F,Dargere D,et al.Identification of a new marker of hepatocellular carcinoma by serum protein profiling of patients with chronic liver diseases [J].Hepatology,2005,41(1):40-47.
11张辉,高春芳,赵光,等.飞行质谱技术筛选肝癌肿瘤标志物的临床意义[J].中华实验外科杂志,2006,23(3):279-281.
12 Ward DG,Cheng Y.Kontchou GN,et al.Changes in the serum proteome associated with the development of hepatocellular carcinoma in hepatitis C-related cirrhosis [J].Br J Cancer,2006,94(2):287-292.
13 Feng JT,Liu YK,Song HY,et al.Heat-shock protein 27:a potential biomarker for hepatocellular carcinoma identified by serum proteome analysis[J].Proteomics, 2005,5(17):4581-88.
14 Marrero JA.Lok AS.Newer markers for hepatocellular carcinoma[J],Gastroenterology, 2004,127(5 Suppl 1):113-119.
15 Pepe MS,Etzioni R,Feng Z,et al.Phases of biomarker development for early detection of cancer[J].J Natl Cancer Inst.2001,93(14):1054-61. |